It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and ...
Erasca Inc. ERAS said it intends to vigorously contest allegations made by Revolution Medicines, Inc. RVMD. Legal Dispute Centers On Patent And Trade Secret Claims On April 24, the company received a ...
Shares of leading tech giant Apple (NASDAQ: AAPL) have been picking up steam in recent weeks. The company has announced a ...
The BioWorld Drug Developers Index underperformed both the Nasdaq Biotechnology Index (NBI) and the Dow Jones Industrial Average (DJIA) throughout February and March. However, it showed some recovery ...
Get all latest & breaking news on Lodha Developers. Watch videos, top stories and articles on Lodha Developers at moneycontrol.com.
Hosted on MSN
Why Weight-Loss Developer Stocks Tumbled on Tuesday
Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, weren't looking so hot on the stock exchange Tuesday. A pronouncement from President Trump about the category ...
The administration might be launching a campaign specifically targeting such products. This would follow Monday's executive order mandating lower drug prices generally. Makers of weight-loss drugs, ...
A clinical-stage biotech is coming for their lunch. It aims to advance its own weight-loss drug to a phase 3 clinical study in the very near future. In the pharmaceutical industry, as in other sectors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results